US Trends

who owns bayer

Bayer does not have a single “owner” – it is a publicly traded German company (Bayer AG) whose shares are widely held by institutional investors and the general public.

Who owns Bayer, in simple terms?

Bayer AG is listed on the Frankfurt Stock Exchange, and its ownership is dispersed among:

  • Large institutional investors (asset managers, pension and mutual funds)
  • Mutual funds and ETFs that hold Bayer as part of broader portfolios
  • Retail investors and other public shareholders around the world

No single company, family, or government directly “controls” Bayer through a majority stake.

Major shareholders (latest public data)

As of mid‑2025 data, some of the largest reported shareholders in Bayer include:

  • BlackRock, Inc. – roughly 6.8–6.9% of shares
  • The Vanguard Group, Inc. – around 4–4.3%
  • Harris Associates L.P. – about 3%
  • Amundi Asset Management – just under 3%
  • Dodge & Cox – about 2.9%
  • Norges Bank Investment Management (Norway’s sovereign wealth fund) – around 1.7%

Overall, mutual funds and ETFs together hold about 31% of Bayer’s common stock, other institutional investors about 7–8%, and public companies plus retail investors roughly 60%.

Here is a compact view of the top institutional holders in HTML table form (as requested):

html

<table>
  <thead>
    <tr>
      <th>Shareholder</th>
      <th>Approx. % of Shares</th>
      <th>Type</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>BlackRock, Inc.</td>
      <td>~6.8–6.9%</td>
      <td>Institutional asset manager</td>
    </tr>
    <tr>
      <td>The Vanguard Group, Inc.</td>
      <td>~4.1–4.3%</td>
      <td>Institutional asset manager</td>
    </tr>
    <tr>
      <td>Harris Associates L.P.</td>
      <td>~3.0%</td>
      <td>Investment management firm</td>
    </tr>
    <tr>
      <td>Amundi Asset Management SAS</td>
      <td>~3.0%</td>
      <td>European asset manager</td>
    </tr>
    <tr>
      <td>Dodge &amp; Cox</td>
      <td>~2.9%</td>
      <td>Investment management firm</td>
    </tr>
    <tr>
      <td>Norges Bank Investment Management</td>
      <td>~1.7%</td>
      <td>Norwegian sovereign wealth fund</td>
    </tr>
    <tr>
      <td>FMR LLC (Fidelity)</td>
      <td>~1.5–1.6%</td>
      <td>Asset manager</td>
    </tr>
  </tbody>
</table>

(Percentages are approximate and can shift over time as investors buy or sell shares.)

How Bayer describes itself today

Bayer presents itself as a life science company focused on health care and agriculture, with businesses in pharmaceuticals, consumer health, and crop science. It traces its origins to 1863 in Germany and is now headquartered in Leverkusen.

Why this is a trending topic

Bayer has been in the news over the last decade because of:

  • Its 2018 acquisition of Monsanto and ensuing glyphosate litigation.
  • Investor pressure and activist shareholders pushing for strategic changes and value recovery.

Those developments often lead people on forums and news sites to ask “who owns Bayer” when they really want to know who has power and influence over its strategic decisions (mainly large institutional shareholders, not a single owner).

Bottom note: Information gathered from public forums or data available on the internet and portrayed here.